基因表达特征,临床病理特征,以及乳腺癌的个性化治疗
Chaitanya R Acharya1, David S Hsu, Carey K Anders
1Duke Institute for Genome Sciences and Policy, Duke University, Durham, North Carolina 27708, USA.
JAMA
|April 5, 2008
概括
将基因表达特征与临床数据相结合,改善了早期乳腺癌患者的预后. 这种基因组方法可以识别不同的亚现象,改善风险分层,并指导个性化治疗策略.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物统计学 生物统计学
背景情况:
- 基因表达造型提供了改善乳腺癌的预后和治疗策略的潜力.
- 准确的预后和量身定制的疗法对于早期乳腺癌管理至关重要.
研究的目的:
- 将基因组信息与临床和病理风险因素相结合.
- 改进预后,提高早期乳腺癌的治疗策略.
主要方法:
- 追溯分析964名乳腺癌早期患者的微阵列数据.
- 应用基因表达特征和临床病理学变量来评估复发风险和化疗敏感性.
- 基因组亚现象的识别及其与复发风险得分的相关性.
主要成果:
- 在不同的风险群体中,确定了与致癌途径和瘤微环境相关的具有预后意义的基因组集群.
- 这些基因组集群独立地改进了与单独的临床病理学模型相比,无复发生存预测.
- 基因组群体对细胞毒性疗法表现出明显的敏感性模式,突出显示异质性.
结论:
- 将基因表达特征纳入临床风险分层显示出改善乳腺癌预后的前景.
- 需要进一步的前性研究来验证这种方法对个性化治疗策略的有用性.
相关概念视频
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
